Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-24

FDA Approved: CALCIPOTRIENE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved a supplemental application for Calcipotriene by Glenmark Pharmaceuticals Inc., USA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcipotriene (calcipotriene)

Snippet

SUPPL AP for CALCIPOTRIENE (CALCIPOTRIENE)